Acumen Pharmaceuticals Inc (NAS:ABOS)
$ 3.8 0.11 (2.98%) Market Cap: 228.30 Mil Enterprise Value: 6.66 Mil PE Ratio: 0 PB Ratio: 0.80 GF Score: 20/100

Acumen Pharmaceuticals Inc at Bank of America Global Healthcare Conference Transcript

May 11, 2023 / 03:00PM GMT
Release Date Price: $5.73 (-13.05%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

All right. Good morning. Welcome to the last day of the BofA Healthcare Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here, and Charlie from my team is on stage with me. So we're thrilled today to do a quick fireside with Acumen Pharma. And speaking on behalf of Acumen, we have CEO, Dan O'Connell. Good to see you.

Daniel J. O;Connell
Acumen Pharmaceuticals, Inc. - CEO, President & Director

' -

Thanks, Geoff. Good to see you. Thanks for having us.

Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Yes, of course.

Daniel J. O;Connell
Acumen Pharmaceuticals, Inc. - CEO, President & Director

' -

Good morning, Charlie.

Chen Yuan Yang
BofA Securities, Research Division - Research Analyst

Good morning.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot